Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
By M. V. Vander Heiden, Lewis C. Cantley, Craig B. Thompson. Science, 2009
15,359 citations recorded by the source corpus.
Fuel Economy for Growing Cells Sophisticated 21st-century analyses of the signaling pathways that control cell growth have led researchers back to the seminal work of Otto Warburg, who discovered in the 1920s that tumor cells generate their energy in an unusual way—by switching from mitochondrial respiration to glycolysis. The advantage conferred by this metabolic switch is puzzling because mitochondrial respiration is a more efficient way to produce ATP. Vander Heiden et al. (p. 1029) review arguments that rapidly growing cells have critical metabolic requirements that extend beyond ATP and that a better understanding of these requirements may shed new light on the “Warburg effect” and ultimately lead to new therapies for cancer. In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed “the Warburg effect.” Aerobic glycolysis is an inefficient way to generate adenosine 5′-triphosphate (ATP), however, and the advantage it confers to cancer cells has been unclear. Here we propose that the metabolism of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell. Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-associated mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP production. A better understanding of the mechanistic links between cellular metabolism and growth control may ultimately lead to better treatments for human cancer.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/5a3b09333eb2968904933e726dc29625e10eb188
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- M. V. Vander Heiden
- Ralph J. Deberardinis
- C. V. Dang
- Navdeep S. Chandel
- Craig B. Thompson
- D. Hanahan
- G. Semenza
- David M. Sabatini
In Molecular Biology
- Guido Kroemer
- David M. Sabatini
- M. V. Vander Heiden
- Ralph J. Deberardinis
- Craig B. Thompson
- C. V. Dang
- Navdeep S. Chandel
- D. Hanahan
Citations in the corpus
- Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids (2013, background): “Oncogenes actively reprogram metabolism to facilitate this supply (1, 2).”
- Cancer as a metabolic disease (2010, background): “HIF-1a expression is also elevated in most tumor cells whether or not hypoxia is present and could mediate in part aerobic glycolysis [20,28,98,128,129].”
- Overcoming intrinsic multi-drug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1Bhigh cells (2013, background): “…factors, including the cancer type and stage, the sequence of oncogenes activated, which can directly influence mitochondrial metabolism, the current microenvironmental context, and also the rate of cell proliferation (Berridge et al., 2010; Jose et al., 2011; Vander Heiden et al., 2009).”
- Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. (2012, positive): “Recent studies have led to an emerging appreciation of the importance of metabolic reprogramming in cancer (Hsu and Sabatini, 2008; Vander Heiden et al., 2009; Hanahan andWeinberg, 2011).”
- Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability (2011, background): “Mammalian cells depend on the catabolism of glucose and glutamine to fuel proliferation (3).”
- Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK During T Lymphocyte Activation (2010, background): “The reliance of activated T cells on glutamine metabolism is strikingly similar to that of tumor cells and may represent a common feature of all rapidly dividing cells (37, 61).”
- Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. (2015, positive): “The dependence on glucose is certainly true for many cancers and is perhaps best illustrated by the clinical value of FDG-PET, which uses a glucose analogue to image and stage tumors (28).”
- Mitochondria and Cancer (2016, background): “In most cancers, oncogenic driver mutations, such as activation of K-ras, c-Myc, and phosphatidylinositol-3 (PI3) kinase or loss of phosphatase and tensin homolog (Pten) and p53, not mutations that inactivate mitochondrial respiration complexes, promote glycolysis (Vander Heiden et al., 2009).”
- Mitochondria: In Sickness and in Health (2012, background): “Mitochondria: In Sickness and in Health”
- The microcosmos of cancer (2012, background): “For example, most cancer cells display alterations in glucose metabolism termed the Warburg effec”